| Literature DB >> 12847287 |
Silke Gillessen1, Yuri N Naumov, Edward E S Nieuwenhuis, Mark A Exley, Frederick S Lee, Nicolas Mach, Andrew D Luster, Richard S Blumberg, Masaru Taniguchi, Steven P Balk, Jack L Strominger, Glenn Dranoff, S Brian Wilson.
Abstract
CD1d-restricted T cells contribute to tumor protection, but their precise roles remain unclear. Here we show that tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor induce the expansion of CD1d-restricted T cells through a mechanism that involves CD1d and macrophage inflammatory protein 2 expression by CD8 alpha-, CD11c+ dendritic cells (DCs). The antitumor immunity stimulated by vaccination with irradiated, granulocyte-macrophage colony-stimulating factor-secreting tumor cells was abrogated in CD1d- and J alpha 281-deficient mice, revealing a critical role for CD1d-restricted T cells in this response. The loss of antitumor immunity was associated with impaired tumor-induced T helper 2 cytokine production, although IFN-gamma secretion and cytotoxicity were preserved. DCs from immunized CD1d-deficient mice showed compromised maturation and function. Together, these results delineate a role for CD1d-restricted T cell-DC cross talk in the shaping of antitumor immunity.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12847287 PMCID: PMC166406 DOI: 10.1073/pnas.1033098100
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205